Clinical Trial Update: Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI) [Phase 2]

View source ↗

Summary

Completed Phase 2 clinical trial evaluating an antimicrobial catheter lock solution for the treatment of central line-associated bloodstream infection (CLABSI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Line-associated Bloodstream Infection

Drugs mentioned

• Antimicrobial Catheter Lock Solution

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Infection | Phase 2 | Status: COMPLETED